Meeting Banner
Abstract #1117

Whole-Body Diffusion-Weighted Imaging at 1.5T for assessment of treatment response in non-Hodgkin lymphoma

Xiaoyi Wang1, Yanfeng Zhao1, Ning Wu1, Han Ouyang1, and Lizhi Xie2

1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China, 2GE Healthcare, MR Research China, BeiJing, People's Republic of China

The diagnostic capability between WBDWI with contrast enhanced CT was compared in malignant lymphoma diagnosis. We found that WBDWI is a powerful tool on diagnosing non-Hodgkin(NHL) lymphoma by comparing with contrast enhanced CT. Chemotherapy causes rapid decrease of the restriction of water molecules diffusion movement, ADC-min could be valuable tools for treatment response evaluation of NHL. We recommended WBDWI examination for patients with NHL.

This abstract and the presentation materials are available to members only; a login is required.

Join Here